These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 29891201)

  • 21. Parotid gland stem cells: Mini yet mighty.
    Sari SY; Yilmaz MT; Elmali A; Yedekci FY; Yuce D; Ozyigit G; Cengiz M; Yazici G
    Head Neck; 2021 Apr; 43(4):1122-1127. PubMed ID: 33244802
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of serial CT images for studying the RT effects in head-neck cancer patients.
    Belli ML; Broggi S; Scalco E; Cattaneo GM; Dell'Oca I; Logghe G; Moriconi S; Sanguineti G; Valentini V; Di Muzio N; Fiorino C; Calandrino R
    Annu Int Conf IEEE Eng Med Biol Soc; 2015; 2015():5235-8. PubMed ID: 26737472
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in salivary gland function after radiotherapy of head and neck tumors measured by quantitative pertechnetate scintigraphy: comparison of intensity-modulated radiotherapy and conventional radiation therapy with and without Amifostine.
    Münter MW; Hoffner S; Hof H; Herfarth KK; Haberkorn U; Rudat V; Huber P; Debus J; Karger CP
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):651-9. PubMed ID: 17175118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Needs and Benefits of Continuous Model Updates on the Accuracy of RT-Induced Toxicity Prediction Models Within a Learning Health System.
    Nakatsugawa M; Cheng Z; Kiess A; Choflet A; Bowers M; Utsunomiya K; Sugiyama S; Wong J; Quon H; McNutt T
    Int J Radiat Oncol Biol Phys; 2019 Feb; 103(2):460-467. PubMed ID: 30300689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel dose constraint to reduce xerostomia in head-and-neck cancer patients treated with intensity-modulated radiotherapy.
    Strigari L; Benassi M; Arcangeli G; Bruzzaniti V; Giovinazzo G; Marucci L
    Int J Radiat Oncol Biol Phys; 2010 May; 77(1):269-76. PubMed ID: 20100642
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Geometric Image Biomarker Changes of the Parotid Gland Are Associated With Late Xerostomia.
    van Dijk LV; Brouwer CL; van der Laan HP; Burgerhof JGM; Langendijk JA; Steenbakkers RJHM; Sijtsema NM
    Int J Radiat Oncol Biol Phys; 2017 Dec; 99(5):1101-1110. PubMed ID: 28939226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of head and neck cancer adaptive radiotherapy to spare the parotid glands and decrease the risk of xerostomia.
    Castelli J; Simon A; Louvel G; Henry O; Chajon E; Nassef M; Haigron P; Cazoulat G; Ospina JD; Jegoux F; Benezery K; de Crevoisier R
    Radiat Oncol; 2015 Jan; 10():6. PubMed ID: 25573091
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NTCP models for patient-rated xerostomia and sticky saliva after treatment with intensity modulated radiotherapy for head and neck cancer: the role of dosimetric and clinical factors.
    Beetz I; Schilstra C; van der Schaaf A; van den Heuvel ER; Doornaert P; van Luijk P; Vissink A; van der Laan BF; Leemans CR; Bijl HP; Christianen ME; Steenbakkers RJ; Langendijk JA
    Radiother Oncol; 2012 Oct; 105(1):101-6. PubMed ID: 22516776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Late xerostomia after intensity-modulated radiation therapy versus conventional radiotherapy.
    Pacholke HD; Amdur RJ; Morris CG; Li JG; Dempsey JF; Hinerman RW; Mendenhall WM
    Am J Clin Oncol; 2005 Aug; 28(4):351-8. PubMed ID: 16062076
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Automated segmentation of the parotid gland based on atlas registration and machine learning: a longitudinal MRI study in head-and-neck radiation therapy.
    Yang X; Wu N; Cheng G; Zhou Z; Yu DS; Beitler JJ; Curran WJ; Liu T
    Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1225-33. PubMed ID: 25442347
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Volumetric and positional changes of planning target volumes and organs at risk using computed tomography imaging during intensity-modulated radiation therapy for head-neck cancer: an "old" adaptive radiation therapy approach.
    Reali A; Anglesio SM; Mortellaro G; Allis S; Bartoncini S; Ruo Redda MG; Arcadipane F
    Radiol Med; 2014 Sep; 119(9):714-20. PubMed ID: 24510758
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is there a clinical benefit to adaptive planning during tomotherapy in patients with head and neck cancer at risk for xerostomia?
    You SH; Kim SY; Lee CG; Keum KC; Kim JH; Lee IJ; Kim YB; Koom WS; Cho J; Kim SK; Kim GE
    Am J Clin Oncol; 2012 Jun; 35(3):261-6. PubMed ID: 21383607
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preventing radiation induced xerostomia.
    Koukourakis MI; Danielidis V
    Cancer Treat Rev; 2005 Nov; 31(7):546-54. PubMed ID: 16257125
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiation-induced volume changes in parotid and submandibular glands in patients with head and neck cancer receiving postoperative radiotherapy: a longitudinal study.
    Wang ZH; Yan C; Zhang ZY; Zhang CP; Hu HS; Kirwan J; Mendenhall WM
    Laryngoscope; 2009 Oct; 119(10):1966-74. PubMed ID: 19688858
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Xerostomia: a day and night difference.
    Dijkema T; Raaijmakers CP; Braam PM; Roesink JM; Monninkhof EM; Terhaard CH
    Radiother Oncol; 2012 Aug; 104(2):219-23. PubMed ID: 22809589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Research advances in prevention of radiation induced xerostomia by intensity-modulated radiation therapy].
    Yan C; Wang ZH
    Shanghai Kou Qiang Yi Xue; 2008 Oct; 17(5):540-4. PubMed ID: 18989600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: results of a nonrandomized prospective study using a standardized follow-up program.
    Vergeer MR; Doornaert PA; Rietveld DH; Leemans CR; Slotman BJ; Langendijk JA
    Int J Radiat Oncol Biol Phys; 2009 May; 74(1):1-8. PubMed ID: 19111400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sub-regional analysis of the parotid glands: model development for predicting late xerostomia with radiomics features in head and neck cancer patients.
    Berger T; Noble DJ; Yang Z; Shelley LE; McMullan T; Bates A; Thomas S; Carruthers LJ; Beckett G; Duffton A; Paterson C; Jena R; McLaren DB; Burnet NG; Nailon WH
    Acta Oncol; 2023 Feb; 62(2):166-173. PubMed ID: 36802351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between patient and physician-rated xerostomia and dose distribution to the oral cavity and salivary glands for head and neck cancer patients after radiotherapy.
    Kaae JK; Johnsen L; Hansen CR; Kristensen MH; Brink C; Eriksen JG
    Acta Oncol; 2019 Oct; 58(10):1366-1372. PubMed ID: 31241381
    [No Abstract]   [Full Text] [Related]  

  • 40. Analysis of the Parotid Glands on an Energy Spectrum CT Iodine Map to Evaluate Irradiation-Induced Acute Xerostomia in Patients With Nasopharyngeal Carcinoma.
    Chen R; Xie J; Chen J; Li X; Lin Q; Xu Q; Chen Y; Wang L; Zheng R; Xu B
    Technol Cancer Res Treat; 2024; 23():15330338241256814. PubMed ID: 38773777
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.